Skip to main content
Ginex, T.; Marco-Marín, C.; Wieczór, M.; Mata, C. P.; Krieger, J.; Ruiz-Rodriguez, P.; López-Redondo, M. L.; Francés-Gómez, C.; Melero, R.; Sánchez-Sorzano, C. O.; Martínez, M.; Gougeard, N.; Forcada-Nadal, A.; Zamora-Caballero, S.; Gozalbo-Rovira, R.; Sanz-Frasquet, C.; Arranz, R.; Bravo, J.; Rubio, V.; Marina, A.; Geller, R.; Comas, I.; Gil, C.; Coscolla, M.; Orozco, M.; Llácer, J. L.; Carazo, J.-M.
[2023]. The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: the case of the spike A222V mutation. Plos Pathogen, 2022, 18, e1010631
Nozal, V.; Martínez-González, L.; Gomez-Almeria, M.; Gonzalo-Consuegra, C.; Santana, P.; Chaikuad, A.; Pérez-Cuevas, E.; Knapp, S.; Lietha, D.; Ramírez, D.; Petralla, S.; Monti, B.; Gil, C.; Martín-Requero, A.; Palomo, V.; de Lago, E.; Martinez, A.
[2022]. TDP-43 modulation by tau-tubulin kinase 1 inhibitors: A new avenue for future Amyotrophic Lateral Sclerosis therapy. J Med Chem 2022, 65, 1585-1607.
Cuesta-Geijo, M.; García-Dorival, I.; Del Puerto, A.; Urquiza, J.; Galindo, I.; Barrado-Gil, L.; Lasala, F.; Cayuela, A.; Sorzano, C. O. S.; Gil, C.; Delgado, R.; Alonso, C.
[2022]. New insights into the role of endosomal proteins for African swine fever virus infection. PLoS Pathog 2022, 18, e1009784.
Martín-Cámara, O.; Arribas, M.; Wells, G.; Morales-Tenorio, M.; Martín-Requero, Á.; Porras, G.; Martínez, A.; Giorgi, G.; López-Alvarado, P.; Lastres-Becker, I.; Menéndez, J. C.
[2022]. Multitarget hybrid fasudil derivatives as a new approach to the potential treatment of amyotrophic lateral sclerosis. J Med Chem 2022, 65, 1867-1882
González-Naranjo, P.; Pérez, C.; Gonzálz-Sánchez, M.; Gironda-Martínez, A.; Ulzurrun, E.; Bartolomé, F.; Rubio-Fernández, M.; Martín-Requro, A.; Campillo, NE.; Páez, J.A.
[2022]. Multitarget drugs as potential therapeutic agents for alzheimer's disease. A new family of 5-substituted indazole derivatives as cholinergic and BACE1 inhibitors. J Enzyme Inhib Med Chem, 2022, 37, 2348-2356
Martínez, M. J.; Sabando, M. V.; Soto, A. J.; Roca, C.; Requena-Triguero, C.; Campillo, N. E.; Páez, J. A.; Ponzoni, I.
[2022]. Multitask deep neural networks for Ames mutagenicity prediction. J Chem Inf Model 2022, 62, 6342-6351
Kocak, M.; Ezazi Erdi, S.; Jorba, G.; Maestro, I.; Farrés, J.; Kirkin, V.; Martinez, A.; Pless, O.
[2022]. Targeting autophagy in disease: established and new strategies. Autophagy 2022, 18, 473-495
Maestro, I.; de la Ballina, L. R.; Porras, G.; Corrochano, S.; De Lago, E.; Simonsen, A.; Boya, P.; Martinez, A.
[2022]. Discovery of mitophagy inhibitors with therapeutic potential in different familial Amyotrophic Lateral Sclerosis mutations. Int J Mol Sci 2022, 23, 12676.
Méndez-Líter, J. A.; Pozo-Rodríguez, A.; Madruga, E.; Rubert, M.; Santana, A. G.; de Eugenio, L. I.; Sánchez, C.; Martínez, A.; Prieto, A.; Martínez, M. J.
[2022]. Glycosylation of epigallocatechin gallate by engineered glycoside hydrolases from Talaromyces amestolkiae: Potential antiproliferative and neuroprotective effect of these molecules. Antioxidants 2022, 11, 1325.
Alegría-Arcos, M.; Barbosa, T.; Sepúlveda, F.; Combariza, G.; González, J.; Gil, C.; Martínez, A.; Ramírez, D.
[2022]. Network pharmacology reveals multi-target mechanism of action of drugs to be repurposed for COVID-19. Front Pharmacol 2022, 13, 952192.
Reggiori, F.; Boya, P.; da Costa, D.; Elazar, Z.; Eskelinen, E. L.; Farrés, J.; Guettler, S.; Kraftk, C.; Jungbluth, H.; Martinez, A.; Morel, E.; Pless, O.; Proikas-Cezanne, T.; Simonsen, A.
[2022]. The mechanism of macroautophagy: the movie. Autophagy Rep 2022, 1, 414-417.
Cogram, P.; Fernández-Beltrán, L. C.; Casarejos, M. J.; Sánchez-Yepes, S.; Rodriguez-Martín, E.; García-Rubia, A.; Sánchez-Barrena, M. J.; Gil, C.; Martínez, A.; Mansilla, A.
[2022]. Inhibition of NCS-1 binding to Ric8a rescues fragile X syndrome mice model phenotypes. Front Neurosci 2022, 16, 1007531.
Sebastián-Pérez, V.; Martinez de Iturrate, P.; Nácher-Vázquez, M.; Nóvoa, L.; Pérez, C.; Campillo, N. E.; Gil, C.; Rivas, L.
[2022]. Naphthoquinone as a new chemical scaffold for leishmanicidal inhibitors of Leishmania GSK-3. Biomedicines 2022, 10, 11
Lasala, F.; García-Rubia, A.; Requena, C.; Galindo, I.; Cuesta-Geijo, M. A.; García-Dorival, I.; Bueno, P.; Labiod, N.; Luczkowiak, J.; Martinez, A.; Campillo, N. E.; Alonso, C.; Delgado, R.; Gil, C.
[2021]. Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic viruses. Antiviral Res. 2021, 186, 105011.
